Comparison of molecular markers for determining the viability and infectivity of Cryptosporidium oocysts and validation of molecular methods against animal infectivity assay

International Journal of Infectious Diseases

Volumn 15, Issue 3, 2011, Pages

  Alum, Absar ^a   Rubino, Joseph R ^b   Khalid Ijaz, M ^b  

^a Arizona State University   (United States)

^b RECKITT BENCKISER   (United Kingdom)

Author keywords

Animal infectivity assay; Cryptosporidium; Molecular markers; Molecular methods; Viability and infectivity of oocysts

Indexed keywords

GLUCAN 1,4 ALPHA GLUCOSIDASE; HEAT SHOCK PROTEIN 70; MICROBICIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL INFECTION; BACTERIAL VIABILITY; CELL CULTURE; COMPARATIVE STUDY; CRYPTOSPORIDIUM; GENE EXPRESSION; GENE TARGETING; GENETIC PROCEDURES; MOUSE; NEWBORN; NONHUMAN; OOCYST; PROTEIN BLOOD LEVEL;

ANIMALS; ANTI-INFECTIVE AGENTS, LOCAL; BIOLOGICAL MARKERS; CELLS, CULTURED; CRYPTOSPORIDIOSIS; CRYPTOSPORIDIUM PARVUM; DNA, PROTOZOAN; GLUCAN 1,4-ALPHA-GLUCOSIDASE; HSP70 HEAT-SHOCK PROTEINS; HUMANS; HYDROGEN PEROXIDE; MICE; MOLECULAR PROBES; OOCYSTS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 79952104396     PISSN: 12019712     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijid.2010.11.005     Document Type: Article

References (25)

1. Fayer R., Xiao L. Cryptosporidium and cryptosporidiosis 2007, CRC press, Boca Raton, FL. 2nd ed.
2. Centers for Disease Control and Prevention. Cryptosporidiosis (Cryptosporidium spp.)-a CDC review. J Environ Health 2004; 67:52.
3. Aiello A.E., Coulborn R.M., Perez V., Larson E.L. Effect of hand hygiene on infectious disease risk in the community setting: a meta-analysis. Am J Public Health 2008, 98:1372-1381.
4. Black E.K., Finch G.R., Taghi-Kilani R., Belosevic M. Comparison of assays for Cryptosporidium parvum oocysts viability after chemical disinfection. FEMS Microbiol Lett 1996, 135:187-189.
5. Bukhari Z., Marshall M.M., Korich D.G., Fricker C.R., Smith H.V., Rosen J., Clancy J.L. Comparison of Cryptosporidium parvum viability and infectivity assays following ozone treatment of oocysts. Appl Environ Microbiol 2000, 66:2972-2980.
6. Jenkins M., Trout J.M., Higgins J., Dorsch M., Veal D., Fayer R. Comparison of tests for viable and infectious Cryptosporidium parvum oocysts. Parasitol Res 2003, 89:1-5.
7. Jenkins M.C., Trout J., Fayer R. Development and application of an improved semiquantitative technique for detecting low-level Cryptosporidium parvum infections in mouse tissue using polymerase chain reaction. J Parasitol 1998, 84:182-186.
8. Di Giovanni G.D., Hashemi F.H., Shaw N.J., Abrams F.A., Le Chevallier M.W., Abbaszadegan M. Detection of infectious Cryptosporidium parvum oocysts in surface and filter backwash water samples by immunomagnetic separation and integrated cell culture-PCR. Appl Environ Microbiol 1999, 65:3427-3432.
9. Gold D., Stein B., Tzipori S. The utilization of sodium taurocholate in excystation of Cryptosporidium parvum and infection of tissue culture. J Parasitol 2001, 87:997-1000.
10. Feng H., Nie W., Sheoran A., Zhang Q., Tzipori S. Bile acids enhance invasiveness of Cryptosporidium spp. into cultured cells. Infect Immun 2006, 74:3342-3346.
11. Sibley L.D. Intracellular parasite invasion strategies. Science 2004, 304:248-253.
12. Yu H., Cook T.J., Sinko P.J. Evidence for diminished functional expression of intestinal transporters in Caco-2 cell monolayers at high passages. Pharm Res 1997, 14:757-762.
13. Choudhry N., Bajaj-Elliott M., McDonald V. The terminal sialic acid of glycoconjugates on the surface of intestinal epithelial cells activates excystation of Cryptosporidium parvum. Infect Immun 2008, 76:3735-3741.
14. Fukuda M., Fukuda M.N. Changes in cell surface glycoproteins and carbohydrate structures during the development and differentiation of human erythroid cells. J Supramol Struct Cell Biochem 1981, 17:313-324.
15. Ryley J.F., Bentley M., Manners D.J., Stark J.R. Amylopectin, the storage polysaccharide of the coccidia Eimeria brunetti and E. tenella. J Parasitol 1969, 55:839-845.
16. Ryley J.F. Cytochemistry, physiology and biochemistry. The coccidia. 1973, 145-181. University Park Press, Baltimore. D.M. Hammond (Ed.).
17. Coppin A., Dzierszinski F., Legrand S., Mortuaire M., Ferguson D., Tomavo S. Developmentally regulated biosynthesis of carbohydrate and storage polysaccharide during differentiation and tissue cyst formation in Toxoplasma gondii. Biochimie 2003, 85:353-361.
18. Schmatz D.M. The mannitol cycle in Eimeria. Parasitology 1997, 114:81-89.
19. Fayer R., Trout J.M., Jenkins M.C. Infectivity of Cryptosporidium parvum oocysts stored in water at environmental temperatures. J Parasitol 1998, 84:1165-1169.
20. Guimaraes E.V., de Carvalho L., Barbosa H.S. An alternative technique to reveal polysaccharides in Toxoplasma gondii tissue cysts. Mem Inst Oswaldo Cruz 2003, 98:915-917.
21. Vetterling J.M., Doran D.J. Storage polysaccharide in coccidial sporozoites after excystation and penetration of cells. J Eukaryot Microbiol 1969, 16:772-775.
22. Guérardel Y., Leleu D., Coppin A., Liénard L., Slomianny C., Strecker G., et al. Amylopectin biogenesis and characterization in the protozoan parasite Toxoplasma gondii, the intracellular development of which is restricted in the HepG2 cell line. Microbes Infect 2005, 7:41-48.
23. Quilez J., Sanchez-Acedo C., Avendano C., del Cacho E., Lopez-Bernad F. Efficacy of two peroxygen-based disinfectants for inactivation of Cryptosporidium parvum oocysts. Appl Environ Microbiol 2005, 71:2479-2483.
24. Weir S.C., Pokorny N.J., Carreno R.A., Trevors J.T., Lee H. Efficacy of common laboratory disinfectants on the infectivity of Cryptosporidium parvum oocysts in cell culture. Appl Environ Microbiol 2002, 68:2576-2579.
25. Finch G.R., Black E.K., Gyürék L., Belosevic M. Ozone inactivation of Cryptosporidium parvum in demand-free phosphate buffer determined by in vitro excystation and animal infectivity. Appl Environ Microbiol 1993, 59:4203-4210.